Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Merck & Co. Inc. buy The Goldman Sachs Group, Inc.

Merck & Co. Inc.
Start price
€86.90
02.12.25 / 50%
Target price
€103.37
02.12.26
Performance (%)
47.87%
Price
€128.50
11:17
Summary
This prediction is currently active. With a performance of 47.87% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 02.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Merck & Co. Inc. 8.621% 8.621%
iShares Core DAX® -1,59 % 5,03 %
iShares Nasdaq 100 -4,15 % -0,13 %
iShares Nikkei 225® -6,30 % 0,53 %
iShares S&P 500 -3,23 % 0,47 %

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Merck & Co. Inc. diskutieren
Prediction Buy
Perf. (%) 47.87%
Target price 103.368
Change
Ends at 02.12.26

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $92.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
02.12.25